Restart Life Sciences Corp. (CSE:HEAL)

Market Cap	3.54M
Revenue (ttm)	n/a
Net Income (ttm)	-449.63K
Shares Out	33.73M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,467
Average Volume	50,820
Open	0.0950
Previous Close	0.1000
Day's Range	0.0900 - 0.1100
52-Week Range	0.0300 - 0.2000
Beta	-0.45
RSI	67.77
Earnings Date	Aug 27, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2004
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: HEAL